Prevalence and clinical correlates of microalbuminuria in children with sickle cell disease

被引:63
作者
Becton, Lauren J. [2 ]
Kalpatthi, Ram V. [3 ]
Rackoff, Elizabeth
Disco, Deborah
Orak, John K.
Jackson, Sherron M.
Shatat, Ibrahim F. [1 ]
机构
[1] Med Univ S Carolina, Childrens Hosp, Div Nephrol, Charleston, SC 29425 USA
[2] Med Univ S Carolina, Childrens Hosp, Dept Pediat, Charleston, SC 29425 USA
[3] Childrens Mercy Hosp, Kansas City, MO 64108 USA
关键词
Hypertension; Microalbuminuria; Pediatrics; Proteinuria; Sickle cell disease; RISK-FACTORS; PROTEINURIA; HYDROXYUREA; THERAPY; ANEMIA;
D O I
10.1007/s00467-010-1536-8
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Sickle cell disease (SCD) is associated with a large spectrum of renal abnormalities, one of which, microalbuminuria/proteinuria (MA/P), is a known predictor of end-stage renal disease. We studied 90 children with SCD (57% male; mean age 11.4 +/- 5.2 years) to determine the prevalence and examine clinical correlates of MA/P. The average of two spot urine microalbumin-to-creatinine samples obtained 6 months apart was recorded. Medical records were reviewed for demographic and biochemical data. Medication use, resting office blood pressures (BP), vaso-occlusive pain crises (VOC), and monthly transfusions were recorded. Fourteen children (15.5%) had MA/P. Hemoglobin (Hb) levels were significantly lower in the children with MA than in those without MA/P (8.8 +/- 1.1 vs. 9.8 +/- 1.4 g/dL, respectively) and were significantly correlated with MA (rho = 0.24, p = 0.03). Children with MA were more likely to have abnormal BP (p = 0.058), with 5/14 being hypertensive or pre-hypertensive. In a multivariate logistic regression model of MA, both Hb and BP classification remained in the final model. MA is a simple screening biomarker of early kidney injury in children with SCD. Larger studies to evaluate predictive factors of MA and the relationship to BP are needed.
引用
收藏
页码:1505 / 1511
页数:7
相关论文
共 27 条
[1]   EFFECTS OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS ON RENAL-FUNCTION IN SICKLE-CELL ANEMIA [J].
ALLON, M ;
LAWSON, L ;
ECKMAN, JR ;
DELANEY, V ;
BOURKE, E .
KIDNEY INTERNATIONAL, 1988, 34 (04) :500-506
[2]   Short-term follow-up of patients with sickle cell disease and albuminuria [J].
Alvarez, Ofelia ;
Lopez-Mitnik, Gabriela ;
Zilleruelo, Gaston .
PEDIATRIC BLOOD & CANCER, 2008, 50 (06) :1236-1239
[3]   Early blood transfusions protect against microalbuminuria in children with sickle cell disease [J].
Alvarez, Ofelia ;
Montane, Brenda ;
Lopez, Gabriela ;
Wilkinson, James ;
Miller, Tracie .
PEDIATRIC BLOOD & CANCER, 2006, 47 (01) :71-76
[4]  
AOKI RY, 1990, BRAZ J MED BIOL RES, V23, P1103
[5]  
Ataga KI, 2000, AM J HEMATOL, V63, P205, DOI 10.1002/(SICI)1096-8652(200004)63:4<205::AID-AJH8>3.3.CO
[6]  
2-#
[7]   Peroxynitrite formation and apoptosis in transgenic sickle cell mouse kidneys [J].
Bank, N ;
Kiroycheva, M ;
Ahmed, F ;
Anthony, GM ;
Fabry, ME ;
Nagel, RL ;
Singhal, PC .
KIDNEY INTERNATIONAL, 1998, 54 (05) :1520-1528
[8]   Microalbuminuria as a predictor of early glomerular injury in children with sickle cell disease [J].
Vikram Datta ;
Janaki Raju Ayengar ;
Shilpaja Karpate ;
Pushpa Chaturvedi .
The Indian Journal of Pediatrics, 2003, 70 (4) :307-309
[9]   IMPAIRED RENAL TUBULAR POTASSIUM SECRETION IN SICKLE-CELL DISEASE [J].
DEFRONZO, RA ;
TAUFIELD, PA ;
BLACK, H ;
MCPHEDRAN, P ;
COOKE, CR .
ANNALS OF INTERNAL MEDICINE, 1979, 90 (03) :310-316
[10]   Prevalence of microalbuminuria in children with sickle cell disease [J].
Dharnidharka, VR ;
Dabbagh, S ;
Atiyeh, B ;
Simpson, P ;
Sarnaik, S .
PEDIATRIC NEPHROLOGY, 1998, 12 (06) :475-478